The impact of the conjugation manner of targeting agent and tandem cell-penetrating peptide on the efficacy of mitomycin C liposomes in treating triple-negative breast tumors.

Salahi, Mehrnaz et al.·International journal of pharmaceutics: X·2025·low (animal study)preclinical study (in vitro and in vivo)
RPEP-13381Preclinical study (in vitro and in vivo)low (animal study)2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
preclinical study (in vitro and in vivo)
Evidence
low (animal study)
Sample
N=N/A (animal study)
Participants
4T1 triple-negative breast cancer cells (in vitro) and tumor-bearing BALB/c mice (in vivo)

What This Study Found

Liposomes coated with poly-L-arginine (cell-penetrating peptide) and chondroitin sulfate (CD44 targeting) delivered mitomycin C to triple-negative breast tumors in mice, achieving the strongest tumor suppression with a Ki-67 index of just 6%.

Key Numbers

PLA-CS liposomes: 144 nm, 73% encapsulation; Ki-67 index 6% (vs higher in controls); caspase-3 upregulated 13-64 fold; G1 cell cycle arrest; no liver/kidney metastasis; sustained MMC release over 24h

How They Did This

Liposome synthesis and characterization (size, PDI, zeta potential, encapsulation). In vitro: MTT cytotoxicity, cellular uptake, apoptosis, cell cycle, qRT-PCR for caspases in 4T1 cells. In vivo: orthotopic 4T1 tumors in BALB/c mice.

Why This Research Matters

Triple-negative breast cancer has few treatment options. Combining a tumor-targeting molecule with a cell-penetrating peptide on drug-carrying nanoparticles could improve chemotherapy delivery while reducing side effects.

What This Study Doesn't Tell Us

Mouse tumor model. Single tumor type (4T1). PLA-CS vs CS-PLA order matters for efficacy, adding manufacturing complexity. Long-term safety not assessed.

Trust & Context

Original Title:
The impact of the conjugation manner of targeting agent and tandem cell-penetrating peptide on the efficacy of mitomycin C liposomes in treating triple-negative breast tumors.
Published In:
International journal of pharmaceutics: X, 10, 100457 (2025)
Database ID:
RPEP-13381

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Cite This Study

RPEP-13381·https://rethinkpeptides.com/research/RPEP-13381

APA

Salahi, Mehrnaz; Varshosaz, Jaleh; Rostami, Mahboubeh; Esfahani, Salar Nasr; Hekmat, Arsham; Jahanian-Najafaabadi, Ali; Minayian, Mohsen. (2025). The impact of the conjugation manner of targeting agent and tandem cell-penetrating peptide on the efficacy of mitomycin C liposomes in treating triple-negative breast tumors.. International journal of pharmaceutics: X, 10, 100457. https://doi.org/10.1016/j.ijpx.2025.100457

MLA

Salahi, Mehrnaz, et al. "The impact of the conjugation manner of targeting agent and tandem cell-penetrating peptide on the efficacy of mitomycin C liposomes in treating triple-negative breast tumors.." International journal of pharmaceutics: X, 2025. https://doi.org/10.1016/j.ijpx.2025.100457

RethinkPeptides

RethinkPeptides Research Database. "The impact of the conjugation manner of targeting agent and ..." RPEP-13381. Retrieved from https://rethinkpeptides.com/research/salahi-2025-the-impact-of-the

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.